These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 36508338)

  • 1. Prevalence and characterization of piperaquine, mefloquine and artemisinin derivatives triple-resistant Plasmodium falciparum in Cambodia.
    Mairet-Khedim M; Roesch C; Khim N; Srun S; Bouillon A; Kim S; Ke S; Kauy C; Kloeung N; Eam R; Khean C; Kul C; Chy S; Leang R; Ringwald P; Barale JC; Witkowski B
    J Antimicrob Chemother; 2023 Feb; 78(2):411-417. PubMed ID: 36508338
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dihydroartemisinin-piperaquine resistance in Plasmodium falciparum malaria in Cambodia: a multisite prospective cohort study.
    Amaratunga C; Lim P; Suon S; Sreng S; Mao S; Sopha C; Sam B; Dek D; Try V; Amato R; Blessborn D; Song L; Tullo GS; Fay MP; Anderson JM; Tarning J; Fairhurst RM
    Lancet Infect Dis; 2016 Mar; 16(3):357-65. PubMed ID: 26774243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution and Temporal Dynamics of Plasmodium falciparum Chloroquine Resistance Transporter Mutations Associated With Piperaquine Resistance in Northern Cambodia.
    Shrestha B; Shah Z; Morgan AP; Saingam P; Chaisatit C; Chaorattanakawee S; Praditpol C; Boonyalai N; Lertsethtakarn P; Wojnarski M; Deutsch-Feldman M; Adams M; Sea D; Chann S; Tyner SD; Lanteri CA; Spring MD; Saunders DL; Smith PL; Lon C; Gosi P; Sok S; Satharath P; Rekol H; Lek D; Vesely BA; Lin JT; Waters NC; Takala-Harrison S
    J Infect Dis; 2021 Sep; 224(6):1077-1085. PubMed ID: 33528566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pfmdr1 copy number and arteminisin derivatives combination therapy failure in falciparum malaria in Cambodia.
    Lim P; Alker AP; Khim N; Shah NK; Incardona S; Doung S; Yi P; Bouth DM; Bouchier C; Puijalon OM; Meshnick SR; Wongsrichanalai C; Fandeur T; Le Bras J; Ringwald P; Ariey F
    Malar J; 2009 Jan; 8():11. PubMed ID: 19138391
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of dihydroartemisinin-piperaquine treatment failure in Plasmodium falciparum malaria in Cambodia, Thailand, and Vietnam: a prospective clinical, pharmacological, and genetic study.
    van der Pluijm RW; Imwong M; Chau NH; Hoa NT; Thuy-Nhien NT; Thanh NV; Jittamala P; Hanboonkunupakarn B; Chutasmit K; Saelow C; Runjarern R; Kaewmok W; Tripura R; Peto TJ; Yok S; Suon S; Sreng S; Mao S; Oun S; Yen S; Amaratunga C; Lek D; Huy R; Dhorda M; Chotivanich K; Ashley EA; Mukaka M; Waithira N; Cheah PY; Maude RJ; Amato R; Pearson RD; Gonçalves S; Jacob CG; Hamilton WL; Fairhurst RM; Tarning J; Winterberg M; Kwiatkowski DP; Pukrittayakamee S; Hien TT; Day NP; Miotto O; White NJ; Dondorp AM
    Lancet Infect Dis; 2019 Sep; 19(9):952-961. PubMed ID: 31345710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Piperaquine resistant Cambodian Plasmodium falciparum clinical isolates: in vitro genotypic and phenotypic characterization.
    Boonyalai N; Vesely BA; Thamnurak C; Praditpol C; Fagnark W; Kirativanich K; Saingam P; Chaisatit C; Lertsethtakarn P; Gosi P; Kuntawunginn W; Vanachayangkul P; Spring MD; Fukuda MM; Lon C; Smith PL; Waters NC; Saunders DL; Wojnarski M
    Malar J; 2020 Jul; 19(1):269. PubMed ID: 32711538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroartemisinin-piperaquine failure associated with a triple mutant including kelch13 C580Y in Cambodia: an observational cohort study.
    Spring MD; Lin JT; Manning JE; Vanachayangkul P; Somethy S; Bun R; Se Y; Chann S; Ittiverakul M; Sia-ngam P; Kuntawunginn W; Arsanok M; Buathong N; Chaorattanakawee S; Gosi P; Ta-aksorn W; Chanarat N; Sundrakes S; Kong N; Heng TK; Nou S; Teja-isavadharm P; Pichyangkul S; Phann ST; Balasubramanian S; Juliano JJ; Meshnick SR; Chour CM; Prom S; Lanteri CA; Lon C; Saunders DL
    Lancet Infect Dis; 2015 Jun; 15(6):683-91. PubMed ID: 25877962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ex vivo susceptibility of Plasmodium falciparum to antimalarial drugs in western, northern, and eastern Cambodia, 2011-2012: association with molecular markers.
    Lim P; Dek D; Try V; Eastman RT; Chy S; Sreng S; Suon S; Mao S; Sopha C; Sam B; Ashley EA; Miotto O; Dondorp AM; White NJ; Su XZ; Char MC; Anderson JM; Amaratunga C; Menard D; Fairhurst RM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5277-83. PubMed ID: 23939897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genetic markers associated with dihydroartemisinin-piperaquine failure in Plasmodium falciparum malaria in Cambodia: a genotype-phenotype association study.
    Amato R; Lim P; Miotto O; Amaratunga C; Dek D; Pearson RD; Almagro-Garcia J; Neal AT; Sreng S; Suon S; Drury E; Jyothi D; Stalker J; Kwiatkowski DP; Fairhurst RM
    Lancet Infect Dis; 2017 Feb; 17(2):164-173. PubMed ID: 27818095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia.
    Parobek CM; Parr JB; Brazeau NF; Lon C; Chaorattanakawee S; Gosi P; Barnett EJ; Norris LD; Meshnick SR; Spring MD; Lanteri CA; Bailey JA; Saunders DL; Lin JT; Juliano JJ
    Genome Biol Evol; 2017 Jun; 9(6):1673-1686. PubMed ID: 28854635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of resistance of Plasmodium falciparum to artesunate-mefloquine combination in an area along the Thai-Myanmar border: integration of clinico-parasitological response, systemic drug exposure, and in vitro parasite sensitivity.
    Na-Bangchang K; Muhamad P; Ruaengweerayut R; Chaijaroenkul W; Karbwang J
    Malar J; 2013 Jul; 12():263. PubMed ID: 23898808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing the asymptomatic reservoir and dihydroartemisinin-piperaquine effectiveness in a low transmission setting threatened by artemisinin resistant Plasmodium falciparum.
    Falq G; Van Den Bergh R; De Smet M; Etienne W; Nguon C; Rekol H; Imwong M; Dondorp A; Kindermans JM
    Malar J; 2016 Sep; 15(1):446. PubMed ID: 27585957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ex Vivo Drug Susceptibility Testing and Molecular Profiling of Clinical Plasmodium falciparum Isolates from Cambodia from 2008 to 2013 Suggest Emerging Piperaquine Resistance.
    Chaorattanakawee S; Saunders DL; Sea D; Chanarat N; Yingyuen K; Sundrakes S; Saingam P; Buathong N; Sriwichai S; Chann S; Se Y; Yom Y; Heng TK; Kong N; Kuntawunginn W; Tangthongchaiwiriya K; Jacob C; Takala-Harrison S; Plowe C; Lin JT; Chuor CM; Prom S; Tyner SD; Gosi P; Teja-Isavadharm P; Lon C; Lanteri CA
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4631-43. PubMed ID: 26014942
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence of Plasmodium falciparum Malaria Multidrug Resistance to Artemisinin and Piperaquine in Western Cambodia: Dihydroartemisinin-Piperaquine Open-Label Multicenter Clinical Assessment.
    Leang R; Taylor WR; Bouth DM; Song L; Tarning J; Char MC; Kim S; Witkowski B; Duru V; Domergue A; Khim N; Ringwald P; Menard D
    Antimicrob Agents Chemother; 2015 Aug; 59(8):4719-26. PubMed ID: 26014949
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
    Smithuis F; Kyaw MK; Phe O; Aye KZ; Htet L; Barends M; Lindegardh N; Singtoroj T; Ashley E; Lwin S; Stepniewska K; White NJ
    Lancet; 2006 Jun; 367(9528):2075-85. PubMed ID: 16798391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Declining artesunate-mefloquine efficacy against falciparum malaria on the Cambodia-Thailand border.
    Wongsrichanalai C; Meshnick SR
    Emerg Infect Dis; 2008 May; 14(5):716-9. PubMed ID: 18439351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of the first-line treatment shift from dihydroartemisinin/piperaquine to artesunate/mefloquine on Plasmodium vivax drug susceptibility in Cambodia.
    Roesch C; Mairet-Khedim M; Kim S; Lek D; Popovici J; Witkowski B
    J Antimicrob Chemother; 2020 Jul; 75(7):1766-1771. PubMed ID: 32211790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evolution of Multidrug Resistance in Plasmodium falciparum: a Longitudinal Study of Genetic Resistance Markers in the Greater Mekong Subregion.
    Imwong M; Suwannasin K; Srisutham S; Vongpromek R; Promnarate C; Saejeng A; Phyo AP; Proux S; Pongvongsa T; Chea N; Miotto O; Tripura R; Nguyen Hoang C; Dysoley L; Ho Dang Trung N; Peto TJ; Callery JJ; van der Pluijm RW; Amaratunga C; Mukaka M; von Seidlein L; Mayxay M; Thuy-Nhien NT; Newton PN; Day NPJ; Ashley EA; Nosten FH; Smithuis FM; Dhorda M; White NJ; Dondorp AM
    Antimicrob Agents Chemother; 2021 Nov; 65(12):e0112121. PubMed ID: 34516247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phenotypic and genotypic characterization of Thai isolates of Plasmodium falciparum after an artemisinin resistance containment project.
    Thita T; Jadsri P; Thamkhantho J; Ruang-Areerate T; Suwandittakul N; Sitthichot N; Mahotorn K; Tan-Ariya P; Mungthin M
    Malar J; 2018 May; 17(1):197. PubMed ID: 29764451
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are k13 and plasmepsin II genes, involved in Plasmodium falciparum resistance to artemisinin derivatives and piperaquine in Southeast Asia, reliable to monitor resistance surveillance in Africa?
    Foguim Tsombeng F; Gendrot M; Robert MG; Madamet M; Pradines B
    Malar J; 2019 Aug; 18(1):285. PubMed ID: 31443646
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.